// App-Quantinova.ai

2401 : Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Researchers

Presenter

  • Mitja Nabergoj

Principal Investigators

  • Dietrich W. Beelen

  • Arnold Ganser

  • Nicolaus Krger

  • Martin Bornhuser

  • Jrgen Finke Sr

  • Jakob R. Passweg

  • Jan J. Cornelissen

  • Natalie Schub

  • Hendrik Veelken

  • Yves Beguin

  • Keith Wilson

  • Tsila Zuckerman

  • Aurelien Giltat

  • Celestine Simand

  • Rocio Parody

  • Pascal Turlure

  • Tessa Kerre

  • Linda Koster

  • Patrick J Hayden

  • Francesco Onida

  • Christof Scheid

  • Yves Chalandon

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • Geneva University Hospitals, Geneva, Switzerland

  • EBMT Statistical Unit,Leiden,Netherlands

  • Department of Stem Cell Transplantation, University of Essen, Essen, Germany,

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • Universitatsklinikum TU Dresden, Dresden, Germany

  • University of Freiburg, Freiburg, Germany, Dept. of Hematology, Oncology and Stem Cell Transplantation,, Freiburg, Germany

  • Haematology, University Hospital, Basel, Switzerland

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Kiel, Germany

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • CHU Liege and University of Liege, Liege, Belgium

  • University Hospital of Wales, Cardiff, United Kingdom

  • Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel

  • Clinical Hematology, Angers University Hospital, Angers, France

  • Clinical Hematology, Strasbourg University Hospital, Strasbourg, France

  • ICO-Hospital Duran i Reynals, Barcelona, Spain

  • Dermatology department, CHU Limoges., Limoges, France

  • Department of Radiation Oncology, Ghent University Hospital, Gent, Belgium

  • EBMT Leyden Office, Leyden, The Netherlands,

  • Trinity College Dublin and St. James's Hospital, Dublin, Ireland

  • BMT Center - Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - University of Milan, Milano, Italy

  • Department of Internal Medicine I, Leukapheresis and Stem Cell Transplant Unit, University of Cologne, Cologne, Germany

  • SBIM, Hopital Saint-Louis, APHP, Paris, France

  • Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France

Locations

  • Switzerland

  • Netherlands

  • Germany

  • Belgium

  • United Kingdom

  • Israel

  • France

  • Spain

  • Ireland

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Breast cancer

  • Graft-versus-host disease

Biomarkers

  • Soluble Complement 5b-9

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved